Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.

Low-grade inflammation, characterized by increased pro-inflammatory cytokine levels, is present in patients with obesity-linked insulin resistance, hyperglycemia and hyperlipidemia and considered to play a leading role to progression into type 2 diabetes (T2D). In adipose tissue in obese patients an...

Full description

Bibliographic Details
Main Authors: Helena Cucak, Dorte Vistisen, Daniel Witte, Annelotte Philipsen, Alexander Rosendahl
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0107140
id doaj-67101a05d48c47e3bd66a50e11bcadf0
record_format Article
spelling doaj-67101a05d48c47e3bd66a50e11bcadf02021-03-04T08:58:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10714010.1371/journal.pone.0107140Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.Helena CucakDorte VistisenDaniel WitteAnnelotte PhilipsenAlexander RosendahlLow-grade inflammation, characterized by increased pro-inflammatory cytokine levels, is present in patients with obesity-linked insulin resistance, hyperglycemia and hyperlipidemia and considered to play a leading role to progression into type 2 diabetes (T2D). In adipose tissue in obese patients and in pancreatic islets in T2D patients cellular inflammation is present. However, the systemic leukocyte compartment and the circulating endothelial/precursor compartment in patients at risk to develop T2D has so far not been analyzed in detail. To address this, peripheral blood cells from a cohort of 20 subjects at risk to develop diabetes with normal to impaired glucose tolerance were analyzed by flow cytometry using a wide range of cellular markers and correlated to known metabolic risk factors for T2D i.e. fasting plasma glucose (FPG), 2 h plasma glucose (2 h PG), HbA1c, body mass index (BMI), homeostasis model assessment of β-cell function (HOMA-B), homeostasis model assessment of insulin sensitivity (HOMA-IS) and fasting insulin (FI). The four highest ranked cell markers for each risk factor were identified by random forest analysis. In the cohort, a significant negative correlation between the number of TLR4(+) CD4 T cells and increased FPG was demonstrated. Similarly, with increased BMI the frequency of TLR4(+) B cells was significantly decreased, as was the frequency of IL-21R(+) CD4 T cells. Unlinked to metabolic risk factors, the frequency of regulatory T cells was reduced and TLR4(+) CD4 T cells were increased with age. Taken together, in this small cohort of subjects at risk to develop T2D, a modulation of the circulating immune cell pool was demonstrated to correlate with risk factors like FPG and BMI. This may provide novel insights into the inflammatory mechanisms involved in the progression to diabetes in subjects at risk.https://doi.org/10.1371/journal.pone.0107140
collection DOAJ
language English
format Article
sources DOAJ
author Helena Cucak
Dorte Vistisen
Daniel Witte
Annelotte Philipsen
Alexander Rosendahl
spellingShingle Helena Cucak
Dorte Vistisen
Daniel Witte
Annelotte Philipsen
Alexander Rosendahl
Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.
PLoS ONE
author_facet Helena Cucak
Dorte Vistisen
Daniel Witte
Annelotte Philipsen
Alexander Rosendahl
author_sort Helena Cucak
title Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.
title_short Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.
title_full Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.
title_fullStr Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.
title_full_unstemmed Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.
title_sort reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Low-grade inflammation, characterized by increased pro-inflammatory cytokine levels, is present in patients with obesity-linked insulin resistance, hyperglycemia and hyperlipidemia and considered to play a leading role to progression into type 2 diabetes (T2D). In adipose tissue in obese patients and in pancreatic islets in T2D patients cellular inflammation is present. However, the systemic leukocyte compartment and the circulating endothelial/precursor compartment in patients at risk to develop T2D has so far not been analyzed in detail. To address this, peripheral blood cells from a cohort of 20 subjects at risk to develop diabetes with normal to impaired glucose tolerance were analyzed by flow cytometry using a wide range of cellular markers and correlated to known metabolic risk factors for T2D i.e. fasting plasma glucose (FPG), 2 h plasma glucose (2 h PG), HbA1c, body mass index (BMI), homeostasis model assessment of β-cell function (HOMA-B), homeostasis model assessment of insulin sensitivity (HOMA-IS) and fasting insulin (FI). The four highest ranked cell markers for each risk factor were identified by random forest analysis. In the cohort, a significant negative correlation between the number of TLR4(+) CD4 T cells and increased FPG was demonstrated. Similarly, with increased BMI the frequency of TLR4(+) B cells was significantly decreased, as was the frequency of IL-21R(+) CD4 T cells. Unlinked to metabolic risk factors, the frequency of regulatory T cells was reduced and TLR4(+) CD4 T cells were increased with age. Taken together, in this small cohort of subjects at risk to develop T2D, a modulation of the circulating immune cell pool was demonstrated to correlate with risk factors like FPG and BMI. This may provide novel insights into the inflammatory mechanisms involved in the progression to diabetes in subjects at risk.
url https://doi.org/10.1371/journal.pone.0107140
work_keys_str_mv AT helenacucak reductionofspecificcirculatinglymphocytepopulationswithmetabolicriskfactorsinpatientsatrisktodeveloptype2diabetes
AT dortevistisen reductionofspecificcirculatinglymphocytepopulationswithmetabolicriskfactorsinpatientsatrisktodeveloptype2diabetes
AT danielwitte reductionofspecificcirculatinglymphocytepopulationswithmetabolicriskfactorsinpatientsatrisktodeveloptype2diabetes
AT annelottephilipsen reductionofspecificcirculatinglymphocytepopulationswithmetabolicriskfactorsinpatientsatrisktodeveloptype2diabetes
AT alexanderrosendahl reductionofspecificcirculatinglymphocytepopulationswithmetabolicriskfactorsinpatientsatrisktodeveloptype2diabetes
_version_ 1714807544659050496